Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Last updated: April 8, 2025
Sponsor: Dogwood Therapeutics Inc.
Overall Status: Active - Recruiting

Phase

2

Condition

Pain

Pain (Pediatric)

Treatment

Placebo

Halneuron

Clinical Study ID

NCT06848348
HAL-CINP-203
  • Ages > 18
  • All Genders

Study Summary

A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female patients aged ≥18 years.

  • Neuropathic pain has been present and is attributed to platinum and/or taxanechemotherapy.

  • Patient has received a cancer chemotherapy regimen that included taxanes and/orplatinum and has no active or discernible disease progression.

Exclusion

Exclusion Criteria:

  • Current neuropathic pain with symptoms similar to CINP but attributed to causesother than platinum or taxane chemotherapy.

  • Patients who have received HAL at any time prior to screening.

Study Design

Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 2
Study Start date:
February 21, 2025
Estimated Completion Date:
August 31, 2026

Connect with a study center

  • APEX Research Group, LLC

    Fair Oaks, California 95628
    United States

    Active - Recruiting

  • Ark Clinical Research

    Fountain Valley, California 92708
    United States

    Active - Recruiting

  • Profound Research LLC

    Pasadena, California 91105
    United States

    Active - Recruiting

  • Providence Medical Foundation

    Santa Rosa, California 95403
    United States

    Active - Recruiting

  • Paradigm Clinical Research

    Wheat Ridge, Colorado 80033
    United States

    Active - Recruiting

  • TOI Clinical Research

    Lakeland, Florida 33812
    United States

    Active - Recruiting

  • Conquest Research LLC

    Orlando, Florida 32832
    United States

    Active - Recruiting

  • Medsol Clinical Research Center, Inc

    Port Charlotte, Florida 33952
    United States

    Active - Recruiting

  • CenExel FCR

    Tampa, Florida 33613
    United States

    Active - Recruiting

  • CenExel ACMR

    Atlanta, Georgia 30331
    United States

    Active - Recruiting

  • Profound Research at OMG Division of Clinical Hematology and Medical Oncology

    Farmington, Michigan 48334
    United States

    Active - Recruiting

  • Circuit Clinical/ SSM St. Clare Cancer Care

    Fenton, Missouri 63026
    United States

    Active - Recruiting

  • Saint Lukes Hospital

    Kansas City, Missouri 64111
    United States

    Active - Recruiting

  • Exel Clinical Research

    Las Vegas, Nevada 89109
    United States

    Active - Recruiting

  • Rubin MD

    Garden City, New York 11530
    United States

    Active - Recruiting

  • Upstate Clinical Research Associates LLC

    Williamsville, New York 14221
    United States

    Active - Recruiting

  • Center for Oncology and Blood Disorders

    Houston, Texas 77030
    United States

    Active - Recruiting

  • CenExel JBR

    Salt Lake City, Utah 84107
    United States

    Active - Recruiting

  • SSM Health Dean Medical Group

    Madison, Wisconsin 53715
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.